OncoSec Medical Incorporated
ONCS
ONCS was delisted on the 23rd of June, 2023.
23 hedge funds and large institutions have $2.26M invested in OncoSec Medical Incorporated in 2016 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 1 closing their positions.
300% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 1
25% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 4
15% more funds holding
Funds holding: 20 → 23 (+3)
47% less capital invested
Capital invested by funds: $4.28M → $2.26M (-$2.03M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$153K |
| 2 |
Nomura Holdings
Tokyo,
Japan
|
+$56K |
| 3 |
VKH
Virtu KCG Holdings
New York
|
+$36.2K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$25.3K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$19K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$964K |
| 2 |
Janney Montgomery Scott
Philadelphia,
Pennsylvania
|
-$31K |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$1.26K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$842 |
| 5 |
Citigroup
New York
|
-$421 |
ONCS Hedge Fund Activity: Q2 2016 in Review
23 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in OncoSec Medical Incorporated (ONCS) for Q2 2016, worth a combined $2.26M — down 47% from $4.28M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new ONCS positions and 1 closed out — a net gain of 3 holders — while 5 added to existing stakes and 4 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $153K. The largest seller was Sabby Management, cutting an estimated $964K.
- 23 institutional investors held OncoSec Medical Incorporated (ONCS) as of Q2 2016, up from 20 in Q1 2016.
- Funds reported $2.26M of OncoSec Medical Incorporated stock for Q2 2016, down 47% quarter-over-quarter.
- 4 funds opened new OncoSec Medical Incorporated positions in Q2 2016 and 1 closed out, a net change of +3 holders.
- The largest OncoSec Medical Incorporated buyer in Q2 2016 was Renaissance Technologies, an estimated $153K added.
- The largest OncoSec Medical Incorporated seller in Q2 2016 was Sabby Management, an estimated $964K sold.
Based on aggregated 13F filings for Q2 2016.